H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 10.4% of adults in Grand Rapids have diagnosed diabetes — 1.6 points below the U.S. 12% figure. Census population 198,917. Michigan Medicare wound biologics: WPS Government Health Administrators (J8). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Grand Rapids clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Grand Rapids storefront.
Platelet Rich Plasma (PRP) Therapy in Grand Rapids, MI for clinics & physicians. PRP therapy systems with… Compliance support & pricing — contact Hawk Medical.
Adult obesity in Grand Rapids is 36.4% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 10.4% of adults in Grand Rapids have diagnosed diabetes — 1.6 points below the U.S. 12% figure. Michigan is outside CDC’s core Diabetes Belt list; use the PLACES city rate anyway. Hawk Medical is the distributor for platelet rich plasma therapy, not a walk-in clinic.
National Platelet Rich Plasma (PRP) Therapy notes (how the product actually works)CDC PLACES (2023, crude) estimates 10.4% of adults in Grand Rapids have diagnosed diabetes — 1.6 points below the U.S. 12% figure. Adult obesity in Grand Rapids is 36.4% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 22.6% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: J8 / WPS Government Health Administrators, sibling states IN. Michigan Department of Health & Human Services is the public-health home. We will not mash those grains into a fake “demand score.”
We are not going to invent a Grand Rapids warehouse or a five-star local review. What you get is platelet rich plasma therapy from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS J8, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 10.4% of adults — 1.6 points below the U.S. 12% figure. Obesity is 36.4%; arthritis is 22.6%. That is place-level BRFSS modeling, not a clinic census and not a Grand Rapids trial.
It is the Census city-proper count — useful as scale for a city under 250k. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Michigan compliance risk.
If you operate in Michigan and another MAC state, say it on the first call. J8 will not port 1:1. We would rather split utilization than watch a sister clinic copy Grand Rapids tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Grand Rapids, MI.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Grand Rapids is J8 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Grand Rapids — 1.6 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Michigan Part B wound biologics follow this contractor (siblings: IN). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Grand Rapids. Useful for joint-program math; still needs a diagnosis and privileging.
No Grand Rapids storefront. Joe Bradley is an active practice owner. platelet rich plasma therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.